SE7700777L - Forfarande for framstellning av substituerade fenylamidiner - Google Patents
Forfarande for framstellning av substituerade fenylamidinerInfo
- Publication number
- SE7700777L SE7700777L SE7700777A SE7700777A SE7700777L SE 7700777 L SE7700777 L SE 7700777L SE 7700777 A SE7700777 A SE 7700777A SE 7700777 A SE7700777 A SE 7700777A SE 7700777 L SE7700777 L SE 7700777L
- Authority
- SE
- Sweden
- Prior art keywords
- procedure
- preparation
- alkoxy
- halogen
- alkyl
- Prior art date
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 101100294102 Caenorhabditis elegans nhr-2 gene Proteins 0.000 abstract 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 1
- 101100073357 Streptomyces halstedii sch2 gene Proteins 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 235000019256 formaldehyde Nutrition 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2895/76A GB1538097A (en) | 1976-01-26 | 1976-01-26 | Substituted phenyl-amidines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7700777L true SE7700777L (sv) | 1977-07-27 |
| SE440501B SE440501B (sv) | 1985-08-05 |
Family
ID=9748048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7700777A SE440501B (sv) | 1976-01-26 | 1977-01-25 | Forfarande for framstellning av substituerade fenylamidoximer |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4146647A (sv) |
| JP (1) | JPS5953895B2 (sv) |
| BE (1) | BE850723A (sv) |
| CA (1) | CA1074797A (sv) |
| CH (1) | CH620901A5 (sv) |
| DE (1) | DE2702119C2 (sv) |
| DK (1) | DK30277A (sv) |
| ES (1) | ES455294A1 (sv) |
| FR (1) | FR2338927A1 (sv) |
| GB (1) | GB1538097A (sv) |
| IE (1) | IE44416B1 (sv) |
| LU (1) | LU76641A1 (sv) |
| NL (1) | NL188573C (sv) |
| SE (1) | SE440501B (sv) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2804576A1 (de) * | 1977-02-15 | 1978-08-17 | Lafon Labor | Phenylamidin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen |
| DE2961710D1 (en) * | 1978-10-09 | 1982-02-18 | Ciba Geigy Ag | 2-(alpha-phenoxy-alkyl)-imidazolines and their salts, their preparation and use, and agents against phytoparasitic and zooparasitic mites containing them |
| DE2965415D1 (en) * | 1978-11-03 | 1983-06-16 | Bayer Ag | Anilinomethyloxime ethers and processes for their production |
| US4260626A (en) * | 1979-03-26 | 1981-04-07 | Richardson-Merrell Inc. | Tetrahydro and imidazoline antisecretory compounds |
| US4616085A (en) * | 1980-06-19 | 1986-10-07 | Petrolite Corporation | Thioethers of imidazolines |
| FR2506764A1 (fr) * | 1981-05-26 | 1982-12-03 | Synthelabo | Derives d'amidoximes, leur preparation et leur application en therapeutique |
| US5227484A (en) * | 1982-01-14 | 1993-07-13 | Merck Patent Gmbh | Anisotropic compounds having nematic phase and liquid crystal mixtures |
| FR2549049B1 (fr) * | 1983-07-13 | 1986-06-20 | Chauvin Blache Lab | Nouvelles amidines, leur procede de preparation et leur application therapeutique |
| US4659363A (en) * | 1983-07-25 | 1987-04-21 | Ciba-Geigy Corporation | N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof |
| GB9509930D0 (en) * | 1995-05-17 | 1995-07-12 | Smithkline Beecham Corp | Method for preparing certain acetonitriles |
| BRPI0707315A2 (pt) * | 2006-01-27 | 2011-05-03 | Hoffmann La Roche | uso de 2-imidazol substituìdo de derivados de imidazolina |
| RU2009112495A (ru) * | 2006-10-19 | 2010-11-27 | Ф. Хоффманн-Ля Рош Аг (Ch) | Аминометил-2-имидазолы со сродством к рецепторам, ассоциированным со следовыми аминами |
| CA2666762C (en) * | 2006-10-19 | 2014-12-30 | F. Hoffmann-La Roche Ag | Aminomethyl-4-imidazoles |
| CA2668454A1 (en) * | 2006-11-02 | 2008-05-08 | F. Hoffmann-La Roche Ag | Substituted 2-imidazoles |
| KR101134226B1 (ko) * | 2006-11-16 | 2012-04-10 | 에프. 호프만-라 로슈 아게 | 치환된 4-이미다졸 |
| JP2010513238A (ja) * | 2006-12-13 | 2010-04-30 | エフ．ホフマン−ラ ロシュ アーゲー | 微量アミン関連受容体（ｔａａｒ）に対するリガンドとしての新規２−イミダゾール |
| US20080146523A1 (en) | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
| EP2114906B1 (en) * | 2007-02-02 | 2014-08-06 | F. Hoffmann-La Roche AG | 2-aminooxazolines as taar1 ligands for cns disorders |
| ES2525229T3 (es) * | 2007-02-15 | 2014-12-19 | F. Hoffmann-La Roche Ag | 2-aminooxazolinas como ligandos de TAAR1 |
| EP2173720A2 (en) | 2007-07-02 | 2010-04-14 | F. Hoffmann-Roche AG | 2-imidazolines having a good affinity to the trace amine associated receptors (taars) |
| EP2173719A1 (en) * | 2007-07-03 | 2010-04-14 | F. Hoffmann-Roche AG | 4-imidazolines and their use as antidepressants |
| CA2694362A1 (en) * | 2007-07-27 | 2009-02-05 | F. Hoffmann-La Roche Ag | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| CA2695071A1 (en) * | 2007-08-02 | 2009-02-05 | F. Hoffmann-La Roche Ag | The use of benzamide derivatives for the treatment of cns disorders |
| JP5341084B2 (ja) * | 2007-08-03 | 2013-11-13 | エフ．ホフマン−ラ ロシュ アーゲー | Ｔａａｒ１リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体 |
| RU2513086C2 (ru) * | 2008-07-24 | 2014-04-20 | Ф.Хоффманн-Ля Рош Аг | Производные 4,5-дигидро-оксазол-2-ила |
| US8242153B2 (en) * | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
| US20100311798A1 (en) * | 2009-06-05 | 2010-12-09 | Decoret Guillaume | 2-aminooxazolines as taar1 ligands |
| US8354441B2 (en) * | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| WO2013137371A1 (ja) * | 2012-03-15 | 2013-09-19 | 興和株式会社 | 新規ピリミジン化合物及びそれらを含有する医薬 |
| KR102537050B1 (ko) | 2016-03-17 | 2023-05-26 | 에프. 호프만-라 로슈 아게 | Taar의 작용제로서 활성을 갖는 5-에틸-4-메틸-피라졸-3-카복스아미드 유도체 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE598730A (sv) * | 1960-01-01 | |||
| US3115525A (en) * | 1960-04-21 | 1963-12-24 | Wassermann S P A Soc It Per Sp | Halogen-substituted amidoximes |
| US3394181A (en) * | 1964-06-29 | 1968-07-23 | Sterling Drug Inc | Phenoxy-lower-alkyl-amidoximes and phenylamino-lower-alkyl-amidoximes |
| US3445517A (en) * | 1966-06-03 | 1969-05-20 | Lilly Co Eli | Aryl acetamidines |
| FR2036958A6 (sv) * | 1969-04-23 | 1970-12-31 | Orsymonde | |
| FR2149264B1 (sv) * | 1971-08-13 | 1974-09-06 | Orsymonde | |
| US3775478A (en) * | 1972-05-30 | 1973-11-27 | Dow Chemical Co | Substituted phenylthioamidines |
| FR2207706B1 (sv) * | 1972-11-24 | 1975-11-28 | Orsymonde | |
| US3939912A (en) * | 1975-03-21 | 1976-02-24 | Continental Oil Company | Method for reducing the production of water from oil wells |
-
1976
- 1976-01-26 GB GB2895/76A patent/GB1538097A/en not_active Expired
-
1977
- 1977-01-11 CH CH27377A patent/CH620901A5/fr not_active IP Right Cessation
- 1977-01-20 DE DE2702119A patent/DE2702119C2/de not_active Expired
- 1977-01-20 IE IE110/77A patent/IE44416B1/en not_active IP Right Cessation
- 1977-01-20 FR FR7701595A patent/FR2338927A1/fr active Granted
- 1977-01-24 ES ES455294A patent/ES455294A1/es not_active Expired
- 1977-01-24 CA CA270,277A patent/CA1074797A/en not_active Expired
- 1977-01-25 SE SE7700777A patent/SE440501B/sv not_active IP Right Cessation
- 1977-01-25 BE BE174356A patent/BE850723A/xx not_active IP Right Cessation
- 1977-01-25 DK DK30277A patent/DK30277A/da not_active Application Discontinuation
- 1977-01-25 LU LU76641A patent/LU76641A1/xx unknown
- 1977-01-25 US US05/762,774 patent/US4146647A/en not_active Expired - Lifetime
- 1977-01-26 JP JP52007602A patent/JPS5953895B2/ja not_active Expired
- 1977-01-26 NL NLAANVRAGE7700806,A patent/NL188573C/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES455294A1 (es) | 1978-01-01 |
| GB1538097A (en) | 1979-01-10 |
| FR2338927B1 (sv) | 1980-10-10 |
| CH620901A5 (sv) | 1980-12-31 |
| JPS52105131A (en) | 1977-09-03 |
| CA1074797A (en) | 1980-04-01 |
| FR2338927A1 (fr) | 1977-08-19 |
| DE2702119A1 (de) | 1977-07-28 |
| SE440501B (sv) | 1985-08-05 |
| NL7700806A (nl) | 1977-07-28 |
| JPS5953895B2 (ja) | 1984-12-27 |
| BE850723A (fr) | 1977-05-16 |
| US4146647A (en) | 1979-03-27 |
| IE44416B1 (en) | 1981-11-18 |
| LU76641A1 (sv) | 1977-06-24 |
| DK30277A (da) | 1977-07-27 |
| NL188573C (nl) | 1992-08-03 |
| IE44416L (en) | 1977-07-26 |
| DE2702119C2 (de) | 1986-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7700777L (sv) | Forfarande for framstellning av substituerade fenylamidiner | |
| ES2058257T3 (es) | Compuestos herbicidas. | |
| FI853622L (fi) | Diarylacetylener, deras framstaellning och anvaendning. | |
| ATE38672T1 (de) | 7-oxabicycloheptan aminosubstituierte prostaglandinaehnliche verbindungen. | |
| SE8103307L (sv) | Nya n-aryl oxazolidinoner-2, deras framstellningssett och deras terapeutiska anvendning | |
| SE8503207D0 (sv) | Pharmacologically active substituted benzamides | |
| JPS55113775A (en) | Manufacture of 4*55perfluoroo1*33dioxolan compound | |
| SE7909916L (sv) | Beta,gamma-dihydropolyprenylalkoholer och farmaceutiska kompositioner innehallande desamma | |
| BG29136A3 (bg) | Метод за получаване на 6,6'-оксибис (4-хало-2н-пиран-3(6н)-они) | |
| SE7509344L (sv) | Tixotropa uretanalkydhartser och sett for deras framstellning. | |
| PT71543A (en) | Process for the preparation of 2-dihalogenomethylene-3-halogen-3-carboalkoxy-5-oxopyrrolidine having plaguicide activity | |
| BG31648A3 (en) | Method for obtaining of cephalosporine | |
| ES2038176T3 (es) | Un procedimiento para la preparacion de derivados del naftaleno. | |
| SE8102337L (sv) | Radiomottagare | |
| FR2643076B1 (fr) | Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline | |
| ES8105992A1 (es) | Un procedimiento para la preparacion de fenil-quinolicidinas | |
| ES525368A0 (es) | Procedimiento para la preparacion de 6-((ciclico amino) alquilamino)tetrahidrotriazolo (3,4-a)ftalazinas | |
| BG34610A3 (en) | Method for preparating 2', 6'- dialkyl- n- (alkoxymethyl)- 2- chloracetanylides | |
| SE7714465L (sv) | Antitumorforeningar och forfarande for framstellning derav | |
| GB1504016A (en) | Fungicidal agents | |
| ES8401966A1 (es) | Procedimiento para preparar las (2,3-dihidro(1,4-benzodioxin-2-il) alcoil) piperidin-4-il-(n-ciano-n'-r) guanidinas. | |
| ES441012A1 (es) | Procedimiento para la produccion de eteres y tioeteres al- quenilicos. | |
| ES464483A1 (es) | Procedimiento para la obtencion de ortoaminoacetofenonas. | |
| ZA838571B (en) | Heterocyclically substituted nitriles,their preparation and their use as drugs | |
| ATE5534T1 (de) | Imidodisulfamide, ihre herstellung und ihre verwendung in pharmazeutischen zusammensetzungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7700777-1 Effective date: 19930810 Format of ref document f/p: F |